Home/Filings/4/0001062993-23-014997
4//SEC Filing

Macdonald R. Loch 4

Accession 0001062993-23-014997

CIK 0001444192other

Filed

Jul 17, 8:00 PM ET

Accepted

Jul 18, 4:34 PM ET

Size

5.3 KB

Accession

0001062993-23-014997

Insider Transaction Report

Form 4
Period: 2023-07-14
Macdonald R. Loch
Chief Medical Officer
Transactions
  • Award

    Stock Options (Right to Buy)

    2023-07-14+60,00060,000 total
    Exercise: $2.64Exp: 2033-07-14Class A Common Shares (60,000 underlying)
Footnotes (1)
  • [F1]Stock options granted on 07/14/2023 under the Acasti Pharma Stock Option Plan, which vest and become exercisable in equal quarterly installments over a period of 36 months.

Issuer

Acasti Pharma Inc.

CIK 0001444192

Entity typeother

Related Parties

1
  • filerCIK 0001653008

Filing Metadata

Form type
4
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 4:34 PM ET
Size
5.3 KB